We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
-2.2%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$78.1B
AUM Growth
-$1.98B
Cap. Flow
-$7.02B
Cap. Flow %
-8.99%
Top 10 Hldgs %
28.7%
Holding
1,440
New
63
Increased
853
Reduced
452
Closed
54

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$11.9B
2
NVDA icon
NVIDIA
NVDA
+$409M
3
ADSK icon
Autodesk
ADSK
+$261M
4
CRM icon
Salesforce
CRM
+$258M
5
CLX icon
Clorox
CLX
+$238M

Sector Composition

Rank Sector Weight
1 Technology 40.82%
2 Materials 22.17%
3 Healthcare 8.64%
4 Industrials 7.37%
5 Financials 5.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CODI icon
1201
Compass Diversified
CODI
$758M
$253K ﹤0.01%
10,947
+1,628
+17% +$36.5K
AFRM icon
1202
Affirm
AFRM
$23.9B
$249K ﹤0.01%
4,084
-1,048
-20% -$58.3K
ATHM icon
1203
Autohome
ATHM
$2.67B
$249K ﹤0.01%
9,604
+294
+3% +$8.47K
CFG icon
1204
Citizens Financial Group
CFG
$30.3B
$249K ﹤0.01%
5,683
-647
-10% -$28.6K
VRE
1205
DELISTED
Veris Residential
VRE
$247K ﹤0.01%
14,870
+1,378
+10% +$24K
EG icon
1206
Everest Group
EG
$14.5B
$246K ﹤0.01%
680
+259
+62% +$97K
ALEX
1207
DELISTED
Alexander & Baldwin
ALEX
$245K ﹤0.01%
13,787
+1,277
+10% +$24.1K
TBLA icon
1208
Taboola.com
TBLA
$1.37B
$244K ﹤0.01%
66,860
-5,293
-7% -$18.9K
GMED icon
1209
Globus Medical
GMED
$10.7B
$243K ﹤0.01%
2,934
-59,571
-95% -$4.7M
CVNA icon
1210
Carvana
CVNA
$68.6B
$242K ﹤0.01%
5,960
-6,185
-51% -$278K
AIV
1211
Aimco
AIV
$387M
$239K ﹤0.01%
26,347
+1,901
+8% +$16.4K
DTE icon
1212
DTE Energy
DTE
$29.5B
$231K ﹤0.01%
1,916
-146
-7% -$18K
GRAB icon
1213
Grab
GRAB
$14.3B
$227K ﹤0.01%
+48,009
New +$218K
SNN icon
1214
Smith & Nephew
SNN
$13.3B
$227K ﹤0.01%
9,240
+4,865
+111% +$129K
PGRE
1215
DELISTED
Paramount Group
PGRE
$226K ﹤0.01%
45,590
+8,684
+24% +$42.9K
ANSS
1216
DELISTED
Ansys
ANSS
$225K ﹤0.01%
666
-346
-34% -$116K
BDN
1217
Brandywine Realty Trust
BDN
$524M
$225K ﹤0.01%
40,185
+7,198
+22% +$40.2K
UNFI icon
1218
United Natural Foods
UNFI
$3.08B
$220K ﹤0.01%
8,039
+3,682
+85% +$84.8K
RDWR icon
1219
Radware
RDWR
$1.1B
$219K ﹤0.01%
9,727
+418
+4% +$9.57K
KW
1220
DELISTED
Kennedy-Wilson Holdings
KW
$215K ﹤0.01%
21,537
+1,995
+10% +$21.8K
MDB icon
1221
MongoDB
MDB
$27.1B
$211K ﹤0.01%
+905
New +$256K
VITL icon
1222
Vital Farms
VITL
$545M
$210K ﹤0.01%
5,579
+2,957
+113% +$105K
NTST
1223
NETSTREIT Corp
NTST
$2.09B
$208K ﹤0.01%
14,729
+1,366
+10% +$21.3K
CSR
1224
Centerspace
CSR
$921M
$207K ﹤0.01%
3,135
+509
+19% +$35.8K
INSP icon
1225
Inspire Medical Systems
INSP
$1.45B
$206K ﹤0.01%
1,113
+384
+53% +$74.5K

Similar funds

VanEck Associates's Q4 2024 Portfolio in Review

As of Q4 2024, VanEck Associates held 1,440 positions worth $78.1B, down 2.5% from $80.1B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

VanEck Associates withdrew a net $7.02B in Q4 2024, closing 54 positions and reducing 452 holdings. Its most notable exit was Bank of New York Mellon, an estimated $9.49M position sold in full.

By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 41% a quarter earlier, followed by Materials and Healthcare.

Against the trend, VanEck Associates opened a new position in Boeing Co 6.00% Series A Preferred Stock worth $251M.

  • VanEck Associates's largest Q4 2024 buy was Boeing Co 6.00% Series A Preferred Stock: 4,123,397 shares worth $251M.
  • VanEck Associates added most to Kinross Gold in Q4 2024, an estimated $440M increase.
  • VanEck Associates's biggest Q4 2024 reduction was Lam Research, cutting an estimated $11.9B.
  • VanEck Associates fully exited Bank of New York Mellon in Q4 2024, selling an estimated $9.49M.
  • VanEck Associates's ten largest holdings make up 29% of its $78.1B portfolio in Q4 2024.
  • VanEck Associates opened 63 new positions and closed 54 in Q4 2024.
  • VanEck Associates's portfolio value fell 2.5% quarter-over-quarter to $78.1B.

Based on VanEck Associates's 13F filing for Q4 2024, filed 29 Jan 2025.